KSHN001126 150mg
CE-24-02
Phase 1 small_molecule completed
Quick answer
KSHN001126 150mg for Healthy Postmenopausal Women is a Phase 1 program (small_molecule) at Amneal Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amneal Pharmaceuticals
- Indication
- Healthy Postmenopausal Women
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed